We’re proud to be part of such a tight-knit community. The more we can stay in touch, the closer we can work together. Click subscribe to receive news and updates about Amylyx.
AMX0035, a Novel Combination Therapeutic Candidate for Treatment of Primary Mitochondrial Diseases
Lead Author: Kent L. Leslie
Published: United Mitochondrial Disease Foundation Mitochondrial Medicine
Date: June 29, 2017
Critical Role for GLP-1 in Symptomatic Post-Bariatric Hypoglycaemia
Lead Author: Colleen M. Craig, MD
Published: Diabetologia
Date: March 1, 2017
Exendin-(9–39) Corrects Fasting Hypoglycemia in SUR-1–/– Mice by Lowering cAMP in Pancreatic β-Cells and Inhibiting Insulin Secretion
Lead Author: Diva D. De León, MD
Published: Metabolism and Bioenergetics
Date: September 1, 2008
Glucagon-Like Peptide-1 is a Physiological Incretin in Rat
Lead Author: Zhili Wang, PhD
Published: Journal of Clinical Investigation
Date: January 1, 1995
Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor
Lead Author: Bernard Thorens, PhD
Published: Diabetes
Date: November 1, 1993